De-implementation of low value castration for men with prostate cancer: protocol for a theory-based, mixed methods approach to minimizing low value androgen deprivation therapy (DeADT)

Overview of attention for article published in Implementation Science, November 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 76 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 12,246 followers.

RT @ImplementSci: De-implementation of low value androgen deprivation therapy (DeADT) for prostate cancer https://t.co/LMwtR6ssC4 #impsci

03 Dec 2018

Reply Repost Favourite

RT @ImplementSci: De-implementation of low value androgen deprivation therapy (DeADT) for prostate cancer https://t.co/LMwtR6ssC4 #impsci

03 Dec 2018

Reply Repost Favourite

De-implementation of low value androgen deprivation therapy (DeADT) for prostate cancer https://t.co/LMwtR6ssC4 #impsci

29 Nov 2018

Reply Repost Favourite

De-implementation of low value castration for men with prostate cancer: protocol for a theory-based, mixed methods approach to minimizing low value androgen deprivation therapy (DeADT) https://t.co/CsWEZ3yyKI https://t.co/sjW6YolDCs

29 Nov 2018

Reply Repost Favourite